MyAverix Finance
US · Healthcare
Prothena Corporation plc (PRTA)
Biotechnology
Prothena Corporation plc (PRTA) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PRTA
Prothena Corporation plc (PRTA) — FAQ
What is PRTA's P/E ratio?
The price-to-earnings (P/E) ratio for Prothena Corporation plc (PRTA) is 25.00 (data as of 2026-05-23).
Does Prothena Corporation plc pay a dividend?
Dividend yield is not available in the current snapshot for Prothena Corporation plc (PRTA). Check the MyAverix Finance app for the latest dividend data.
What sector is Prothena Corporation plc in?
Prothena Corporation plc (PRTA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is PRTA listed on?
PRTA is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.